Progress in Drug and Formulation Development for the Chemoprevention of Oral Squamous Cell Carcinoma: A Review

Recent Patents on Drug Delivery & Formulation
Himangshu SarmaHemanta K Sharma

Abstract

Cancer is a life-threatening global problem with high incidence rates. Prioritizing the prevention of cancer, chemopreventive agents have drawn much attention from the researchers. This review focuses on the discussion of the progress in the development of chemopreventive agents and formulations related to the prevention of oral cancer. In this perspective, an extensive literature survey was carried out to understand the mechanism, control and chemoprevention of oral cancer. Different patented agents and formulations have also exhibited cancer preventive efficacy in experimental studies. This review summarizes the etiology of oral cancer and developments in prevention strategies. The growth of oral cancer is a multistep activity necessitating the accumulation of genetic as well as epigenetic alterations in key regulatory genes. Many risk factors are associated with oral cancer. Genomic technique for sequencing all tumor specimens has been made available to help detect mutations. The recent development of molecular pathway and genetic tools has made the process of diagnosis easier, better forecast and efficient therapeutic management. Different chemical agents have been studied for their efficacy to prevent oral cancer and some ...Continue Reading

References

May 1, 1992·Archives of Otolaryngology--head & Neck Surgery·K R JonesW W Shockley
Dec 1, 1994·Cancer Metastasis Reviews·L J Marnett
Jan 1, 1996·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·D T WongR B Donoff
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·M TsujiiR N DuBois
Mar 2, 1999·Journal of the National Cancer Institute·E Giovannucci
Apr 10, 1999·The Journal of Biological Chemistry·K SubbaramaiahA J Dannenberg
May 4, 2000·Journal of the National Cancer Institute·M L GillisonD Sidransky
Jun 6, 2000·The American Journal of Clinical Nutrition·H Mukhtar, N Ahmad
Aug 5, 2000·The Journal of Nutrition·A Scalbert, G Williamson
Oct 4, 2000·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·K NylanderP A Hall
Oct 18, 2000·Current Medicinal Chemistry·K M LeahyJ L Masferrer
Apr 28, 2001·Neoplasia : an International Journal for Oncology Research·O GalloE Masini
Jun 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·S Senel, A A Hincal
Nov 6, 2001·Journal of the National Cancer Institute. Monographs·C A Squier, M J Kremer
Feb 21, 2002·Journal of the National Cancer Institute·Michael J ThunCarlo Patrono
Mar 20, 2002·Addiction Biology·C R TrivedyS Warnakulasuriya
Apr 19, 2002·Nutrition and Cancer·M R SartippourM Nguyen
Aug 2, 2002·The Laryngoscope·Zhi WangStanley M Shapshay
Aug 9, 2002·Oral Oncology·Lado Lako LoroOlav Karsten Vintermyr
Aug 9, 2002·Oral Oncology·Ingeborg Klaassen, Boudewijn J M Braakhuis
Nov 9, 2002·Experimental Biology and Medicine·Edward Giovannucci
Apr 5, 2003·Oral Oncology·C AndreadisD Mouratidou
Jun 6, 2003·International Journal of Pharmaceutics·Young-Il JeongShin Jung
Jun 11, 2003·Progress in Experimental Tumor Research·Jae-Won Soh, I Bernard Weinstein
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Masayasu IwaseMasao Nagumo
Aug 2, 2003·Cancer Letters·Zhi WangStanley M Shapshay
Aug 7, 2003·Current Opinion in Pharmacology·Steven J ShiffDiana L Santini
Aug 20, 2003·Archives of Otolaryngology--head & Neck Surgery·Zhi WangStanley M Shapshay
Aug 20, 2003·International Journal of Cancer. Journal International Du Cancer·Yongdoo ChoiYoungro Byun
Jun 11, 2004·Annual Review of Nutrition·Dianne Robert SopranoKenneth J Soprano
Jun 16, 2004·CA: a Cancer Journal for Clinicians·Anne S TsaoWaun Ki Hong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Related Papers

Medicina oral : órgano oficial de la Sociedad Española de Medicina Oral y de la Academia Iberoamericana de Patología y Medicina Bucal
E G Contreras VidaurreE F Torres Cifuentes
Drug Design, Development and Therapy
Xin JiangGuoyue Lv
Annual Review of Medicine
Edward S KimFadlo Raja Khuri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
G AlmadoriM Maurizi
© 2022 Meta ULC. All rights reserved